The field of nanotechnology has revolutionized various scientific disciplines, including medicine, where it offers a promising approach to cancer therapy. This paper delves into the current trends of nanotechnology applications in cancer therapy, highlighting recent advancements and future directions. Nanoparticles, being the backbone of nanotechnology, have demonstrated their potential in delivering therapeutic agents directly to cancer cells, thereby enhancing efficacy and reducing side effects. The abstract further discusses the use of nanotechnology in targeted drug delivery, imaging, and diagnostic procedures. Additionally, it explores the challenges associated with the development and implementation of nanotechnology in clinical settings and examines the regulatory frameworks in place to ensure patient safety. The paper concludes with an outlook on the future of nanotechnology in cancer therapy, emphasizing the need for interdisciplinary collaboration and continued research to overcome existing limitations.
Smith, O. Nanotechnology in Cancer Therapy: Current Trends. Advanced Sciences, 2023, 5, 36. https://doi.org/10.69610/j.as.20230225
AMA Style
Smith O. Nanotechnology in Cancer Therapy: Current Trends. Advanced Sciences; 2023, 5(1):36. https://doi.org/10.69610/j.as.20230225
Chicago/Turabian Style
Smith, Olivia 2023. "Nanotechnology in Cancer Therapy: Current Trends" Advanced Sciences 5, no.1:36. https://doi.org/10.69610/j.as.20230225
APA style
Smith, O. (2023). Nanotechnology in Cancer Therapy: Current Trends. Advanced Sciences, 5(1), 36. https://doi.org/10.69610/j.as.20230225
Article Metrics
Article Access Statistics
References
Burbules, N. C., & Callister, T. A. (2000). Watch IT: The Risks and Promises of Information Technologies for Education. Westview Press.
Prato, M., & Ferrari, M. (2010). Nanomaterials in drug delivery and diagnostics. Chemistry & Biology, 17(1), 1-10.
Zhang, M., & Nie, S. M. (2003). Imaging and delivery of macromolecular drugs using multifunctional nanoparticles. Advanced Drug Delivery Reviews, 55(7), 889-913.
Torchilin, V. P. (2007). Nanocarriers for drug delivery and imaging. Current Pharmaceutical Design, 13(21), 2245-2266.
Maeda, H. (2007). The EPR effect and the limitations of EPR delivery and imaging by Macrocyclic Peptides and Other Macromolecules. Adv Drug Deliv Rev, 59(14), 1217-1239.
El-Sayed, M. A. (2011). The gold rush in nanomaterials: opportunities and challenges. Advanced Materials, 23(10), 1213-1235.
Nie, S. M., & Xing, D. (2012). Quantum dots for cancer imaging and therapy. Advances in Pharmacology, 64, 209-259.
Langer, R., & Tirrell, D. A. (2004). Designing materials for biology and medicine. Nature, 428(6980), 487-492.
El-Sayed, M. A., & El-Sayed, I. A. (2007). Gold and its nanoparticles in biomedicine: applications, considerations and constraints. Materials Horizons, 1(1), 20-30.
Xia, Y., & El-Sayed, M. A. (2007). Cancer therapy with plasmonic nanomaterials. Advances in Drug Delivery Reviews, 59(14), 1240-1250.
Huang, X., & El-Sayed, M. A. (2008). Gold nanorods: the controversy and the coming of age. Advanced Drug Delivery Reviews, 60(13), 1341-1359.